|
Issue |
Title |
|
Vol 10, No 2 (2017) |
COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA |
Abstract
PDF (Rus)
|
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov |
|
Vol 14, No 2 (2021) |
Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries |
Abstract
PDF (Rus)
|
A. B. Ismoilova, N. M.U. Sultanbaeva, A. A. Abdurakhmanov, Sh. Z. Umarova, D. Kh. Dzhalalova, S. Ch. Dzhalalov |
|
Vol 18, No 1 (2025) |
Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms |
Abstract
PDF (Rus)
|
A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya |
|
Vol 12, No 2 (2019) |
Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers |
Abstract
PDF (Rus)
|
E. V. Radchenko, A. S. Kolbin |
|
Vol 16, No 2 (2023) |
Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination |
Abstract
PDF (Rus)
|
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova |
|
Vol 10, No 3 (2017) |
Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients |
Abstract
PDF (Rus)
|
N. K. Mazina, P. V. Mazin |
|
Vol 8, No 3 (2015) |
COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS |
Abstract
PDF (Rus)
|
A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova |
|
Vol 9, No 4 (2016) |
COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY |
Abstract
PDF (Rus)
|
V. S. Dombrovskiy, G. R. Khachatryan |
|
Vol 17, No 1 (2024) |
Compounding pharmacy regulations: experience of the Latvian pharmaceutical market |
Abstract
PDF (Rus)
|
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
|
Vol 16, No 1 (2023) |
Compounding pharmacy regulations: experience of the North American pharmaceutical market |
Abstract
PDF (Rus)
|
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
|
Online First |
Comprehensive analysis of the relationships between somatometric, biochemical and clinical indicators of the condition of patients with chronic kidney diseases |
Abstract
PDF (Rus)
|
I. Yu. Torshin, N. Z. Bashun, O. A. Gromova, A. V. Chekel, A. A. Levchuk, S. N. Lazarevich |
|
Vol 15, No 4 (2022) |
Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression |
Abstract
PDF (Rus)
|
D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin |
|
Vol 13, No 4 (2020) |
Concept of value-based healthcare |
Abstract
PDF (Rus)
|
N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov |
|
Vol 12, No 2 (2019) |
Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine |
Abstract
PDF (Rus)
|
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava |
|
Vol 9, No 3 (2016) |
COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE |
Abstract
PDF (Rus)
|
A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii |
|
Online First |
Cosmetics as a product group of the Russian pharmaceutical market: competition and level of dominance analysis |
Abstract
PDF (Rus)
|
N. I. Markov, L. S. Treshchetkina |
|
Vol 5, No 2 (2012) |
COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS |
Abstract
PDF (Rus)
|
A. V. Rudakova |
|
Vol 9, No 4 (2016) |
COST MINIMIZATION SHALL NOT KILL PEOPLE FINAL RELEASE OF VII RUSSIAN CONGRESS OF PATIENTS |
Abstract
PDF (Rus)
|
Editorial article |
|
Vol 5, No 1 (2012) |
COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS |
Abstract
|
R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko |
|
Vol 17, No 2 (2024) |
Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy |
Abstract
PDF (Rus)
|
S. K. Zyryanov, I. N. Dyakov |
|
Vol 9, No 1 (2016) |
COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA |
Abstract
PDF (Rus)
|
G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy |
|
Vol 16, No 3 (2023) |
Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia |
Abstract
PDF (Rus)
|
N. A. Avxentyev, Yu. V. Makarova |
|
Vol 16, No 1 (2023) |
Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program |
Abstract
PDF (Rus)
|
T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina |
|
Vol 6, No 2 (2013) |
COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS |
Abstract
|
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov |
|
Vol 15, No 1 (2022) |
Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation |
Abstract
PDF (Rus)
|
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg |
|
Vol 10, No 2 (2017) |
COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD |
Abstract
PDF (Rus)
|
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov |
|
Vol 10, No 2 (2017) |
COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD |
Abstract
PDF (Rus)
|
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov |
|
Vol 10, No 2 (2017) |
COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS |
Abstract
PDF (Rus)
|
M. B. Kubaeva, Y. Sh. Guchshina |
|
Vol 10, No 2 (2017) |
COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS |
Abstract
PDF (Rus)
|
M. B. Kubaeva, Y. Sh. Gushchina |
|
Vol 11, No 4 (2018) |
Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis |
Abstract
PDF (Rus)
|
I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina |
|
Vol 6, No 3 (2013) |
COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS |
Abstract
|
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov |
|
Vol 5, No 3 (2012) |
COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES |
Abstract
|
M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova |
|
Vol 13, No 1 (2020) |
COVID-19 in Moscow: prognoses and scenarios |
Abstract
PDF (Rus)
|
M. V. Tamm |
|
Vol 14, No 3 (2021) |
COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation |
Abstract
PDF (Rus)
|
D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy |
|
Vol 13, No 2 (2020) |
COVID-19 pandemic: protective role of vitamin D |
Abstract
PDF (Rus)
|
O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina |
|
Vol 12, No 4 (2019) |
Crucial areas of the economic analysis of public cancer care |
Abstract
PDF (Rus)
|
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova |
|
Vol 15, No 2 (2022) |
Current opportunities for the export of medical services in Russia |
Abstract
PDF (Rus)
|
S. V. Russkikh, E. A. Tarasenko, S. I. Grin, M. T. Yugay, K. K. Kryukova, L. I. Moskvicheva |
|
Vol 11, No 2 (2018) |
Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review |
Abstract
PDF (Rus)
|
T. P. Bezdenezhnykh, D. V. Lukyantseva |
|
Vol 11, No 1 (2018) |
CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation |
Abstract
PDF (Rus)
|
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin |
|
Vol 17, No 2 (2024) |
Cystatin C: diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
D. I. Korabelnikov, M. O. Magomedaliev |
|
Vol 17, No 3 (2024) |
Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
M. O. Magomedaliev, D. I. Korabelnikov |
|
Vol 10, No 3 (2017) |
Decision modelling for the evaluation of diabetes outcomes |
Abstract
PDF (Rus)
|
A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin |
|
Vol 8, No 1 (2015) |
DEFINING THE MAIN TYPES OF RESEARCH AND DEVELOPMENT FOR PURPOSES OF SHAPING STATE R&D POLICY IN RUSSIA AND IN OECD COUNTRIES |
Abstract
PDF (Rus)
|
O. V. Bogacheva, O. A. Feoktistova |
|
Vol 11, No 3 (2018) |
Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies |
Abstract
PDF (Rus)
|
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov |
|
Vol 12, No 4 (2019) |
Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method |
Abstract
PDF (Rus)
|
O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh |
|
Vol 17, No 4 (2024) |
Development of a classification of anesthetic management methods and protocols for calculating financial costs |
Abstract
PDF (Rus)
|
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov |
|
Vol 5, No 3 (2012) |
DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS |
Abstract
PDF (Rus)
|
F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin |
|
Vol 13, No 4 (2020) |
Development of a method for calculation of demand for medical personnel in the healthcare of the Russian Federation, using a mathematical model |
Abstract
PDF (Rus)
|
V. V. Omelyanovsky, T. V. Semenova, D. V. Lukyantseva, D. V. Fedyaev, E. A. Shalaeva |
|
Vol 14, No 1 (2021) |
Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy |
Abstract
PDF (Rus)
|
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov |
|
Vol 16, No 1 (2023) |
Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients |
Abstract
PDF (Rus)
|
I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova |
|
101 - 150 of 518 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |